Alnylam Pharmaceuticals Inc (ALNY) valuation · P/E 39, rev $3.71B
Alnylam Pharmaceuticals Inc (ALNY) P/E 39, rev $3.71B.
| Metric | Value |
|---|---|
| P/E | 39 |
| Market cap | $40.46B |
| Revenue | $3.71B |
| P/S | 10.9 |
ALNY valuation FAQ
What is ALNY's P/E ratio?
Alnylam Pharmaceuticals Inc (ALNY) trailing P/E is 39 on the latest cached fundamentals snapshot.
What is ALNY's market cap?
Alnylam Pharmaceuticals Inc (ALNY) market cap is $40.46B on the latest cached fundamentals snapshot.
What is ALNY's latest revenue?
Latest cached Alnylam Pharmaceuticals Inc (ALNY) revenue was $3.71B. Statements: https://lician.com/financials/alny
What is ALNY's price-to-sales ratio?
Alnylam Pharmaceuticals Inc (ALNY) price-to-sales (P/S) is 10.9, cached market cap $40.46B divided by revenue $3.71B.
How many ALNY valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Alnylam Pharmaceuticals Inc (ALNY): P/E, Market cap, Revenue, and P/S.
Where is ALNY valuation listed?
Cached valuation multiples for Alnylam Pharmaceuticals Inc (ALNY) are listed at https://lician.com/valuation/alny.
Not investment advice. Cached rows, not a live tape.